QT Interval Effects Study of Oral FXS5626 Tablets

Clinical trial NCT07695779 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07695779
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Evaluation of QTc Interval

Start date: 2026-08-05
Primary completion: 2026-09-25
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.